ROCHESTER, MINN. -- Mayo Clinic researchers have found a new clue in the search for a way to stop the tissue damage, or demyelination, that occurs in multiple sclerosis (MS) or related central nervous system diseases. They found a dramatic increase in a newly discovered degradative enzyme, myelencephalon-specific protease (MSP), in demyelinated tissue, indicating that inhibiting this enzyme could potentially block the process of tissue damage.
This is a first-ever finding of the link between MSP and the debilitation that patients experience in MS.
This study will be published in the June 2002 issue of Brain, published by Oxford University Press, http://brain.oupjournals.org/.
"If you could control this enzyme, you could possibly decrease the development of disease," said Isobel Scarisbrick, Ph.D., Mayo Clinic neuroscientist and lead author of this study. "Excess MSP, as is present in inflammatory central nervous system lesions such as those in MS, may promote demyelination."
Dr. Scarisbrick and colleagues discovered MSP in 1997 while she was a research fellow at Mayo Clinic in Jacksonville, Fla. They cloned MSP and developed probes and other tools to work with the enzyme and attempt to determine its role in demyelination.
In the researchers' investigation of mouse and human MS tissue, they discovered MSP's dramatic increase in inflammatory cells in actively demyelinating human MS lesions. MSP is a multifunctional enzyme, facilitating entry of inflammatory cells into the brain and also contributing to tissue destruction when overexpressed. It also may harm processes of the oligodendroglia, cells found in the central nervous system that form the myelin sheath protecting the axon, a component of
nerve cells. When functioning normally, however, MSP contributes to proper oligodendroglia function.
In the MS field, researchers have made many strides in learning about thePage: 1 2 Related medicine news :1
Contact: Lisa Copeland
. Mayo Clinic discovers new pathway against pancreatic cancer2
. Mayo Clinic develops first genomic-based test to predict stroke from ruptured brain aneurysm3
. Mayo Clinic study sets threshold for valve repair surgery4
. Mayo Clinic researcher calls for improved newborn screening5
. Mayo Clinic study finds obese kidney donors face few increased risks6
. Mayo Clinic identifies key cellular process in prostate and other cancers7
. Clinical breast examination offers modest benefit to breast cancer screening program8
. Mayo Clinic researchers create obedient virus; First step to use measles virus against cancer9
. Clinicians report missing patient information is common10
. Mayo Clinic discovers a key to low metabolism and major factor in obesity11
. Clinical trial of Etanercept for Wegeners disease shows no benefit